Page 2 - Andreas Kj News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Positive interim data from phase lla trial of FG001 in head & neck cancer presented as a case report at the World Molecular Imaging Congress in Prague

FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to see the first data from FG001 study guiding cancer surgery in patients with head & neck cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague. The presentation contains a patient case. The poster “Optical-Guided Surgery in Patients .

Czech republicFluoguideas fluoguideAndreas kjAnders christensenWorld molecular imaging congressGuided surgeryOropharyngeal squamous cell carcinomaNear infrared imaging agent

Curasight to present at HC Andersen Capital and Økonomisk Ugebrev

Copenhagen, Denmark, 26 May 2023 - Curasight A/S hereby announces that CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the company s Interim Report Q1 2023 at HC. | May 26, 2023

Ulrich krasilnikoffCurasightas curasightAndreas kjLife science investor conferencePositron emissions tomographyCurasightas stock exchangePress releaseT curas dk0061295797

Curasight: Interim report Q1 2023

Curasight: Interim report Q1 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ulrich krasilnikoffAndreas kjCurasightas curasightCurium incRedeye fight cancer seminarAnnual reportAnnual general

Curasight: Interim report Q1 2023 | MarketScreener

COPENHAGEN, Denmark, May 25, 2023 /PRNewswire/ Curasight A/S hereby publishes the interim report Q1 2023. The interim report is available as an attached file to this release and on the. | May 25, 2023

Ulrich krasilnikoffAndreas kjCurasightas curasightCurium incRedeye fight cancer seminarAnnual reportAnnual generalCurasightas stock exchangePress releaseN curas dk0061295797